Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
FindCure Biosciences (ZhongShan) Co., Ltd.
Eastern Cooperative Oncology Group
Kaiser Permanente
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
University of Nebraska
Adela, Inc
Eli Lilly and Company